<DOC>
	<DOCNO>NCT02910778</DOCNO>
	<brief_summary>To test effect atorvastatin placebo combination ticagrelor ACh-induced vasodilatation forearm resistance vasculature assess forearm blood flow ( FBF ) measurement 10 min 20 min forearm ischemia . The area dose-effect curve ( AUC ) different ACh dos calculate compare treatment group ( atorvastatin + ticagrelor vs. placebo + ticagrelor ) different time point ( pre-ischemia vs. post-ischemia ) .</brief_summary>
	<brief_title>The Effect Ticagrelor With Without Atorvastatin Endothelial Function Healthy Males</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Healthy male subject ; 18 40 year age Body mass index 18 27 kg/m2 Written inform consent Normal find medical &amp; bleed history Nonsmoking Regular intake medication include OTC drug herbal within 2 week IMP administration Known coagulation disorder ( e.g . haemophilia , von WillebrandÂ´s disease ) Known disorder increase bleed risk ( e.g . peridontosis , haemorrhoid , acute gastritis , peptic ulcer , intestinal ulcer ) Known sensitivity common cause bleeding ( e.g . nasal ) History thromboembolism History occlusive vascular disease History vascular anomaly History hypercholesterolemia History myopathy Impaired liver function ( AST , ALT , gGT , bilirubin &gt; 3 x ULN ) Impaired renal function ( serum creatinine &gt; 1.3 mg/dl ) Elevated creatininekinase serummyoglobin ( &gt; 3 x ULN ) Any relevant deviation normal range clinical chemistry , haematology urine analysis HIV1/2Ab , HbsAg HCVAb positive serology Systolic blood pressure 145 mmHg , diastolic blood pressure 95 mmHg Known allergy test agent study Regular daily consumption litre xanthinecontaining beverage 40g alcohol Participation another clinical trial precede 3 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>